Network Meta-Analysis of Ulcerative Colitis Pharmacotherapies: Carryover Effects from Induction and Bias of the Results
UMass Chan AffiliationsDepartment of Population and Quantitative Health Sciences
Document TypeLetter to the Editor
Digestive System Diseases
Research Methods in Life Sciences
MetadataShow full item record
AbstractDear Editor, In their network meta-analyses (NMAs) of treatments for ulcerative colitis (UC), Singh et al1 did not take into account a complication associated with studies that re-randomized patients for the maintenance phase: differential carryover effects from induction can bias the results. In those studies, patients who responded to induction were re-randomized to maintenance treatments that included placebo. If, however, carryover effects from induction differ substantially among active treatments, the effects of those treatments, relative to placebo, are not comparable.
Naessens D, Cameron C, Hoaglin DC. Network Meta-Analysis of Ulcerative Colitis Pharmacotherapies: Carryover Effects from Induction and Bias of the Results. Clin Gastroenterol Hepatol. 2020 Oct 13:S1542-3565(20)31428-2. doi: 10.1016/j.cgh.2020.10.016. Epub ahead of print. PMID: 33065309. Link to article on publisher's site